BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 36085271)

  • 1. Impact of Adding Mean Apparent Diffusion Coefficient (ADCmean) Measurements to O-RADS MRI Scoring For Adnexal Lesions Characterization: A Combined O-RADS MRI/ADCmean Approach.
    Elshetry ASF; Hamed EM; Frere RAF; Zaid NA
    Acad Radiol; 2023 Feb; 30(2):300-311. PubMed ID: 36085271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Added Value of Quantitative Analysis of Diffusion-Weighted Imaging in Ovarian-Adnexal Reporting and Data System Magnetic Resonance Imaging.
    Hottat NA; Badr DA; Van Pachterbeke C; Vanden Houte K; Denolin V; Jani JC; Cannie MM
    J Magn Reson Imaging; 2022 Jul; 56(1):158-170. PubMed ID: 34797013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How to improve O-RADS MRI score for rating adnexal masses with cystic component?
    Assouline V; Dabi Y; Jalaguier-Coudray A; Stojanovic S; Millet I; Reinhold C; Bazot M; Thomassin-Naggara I;
    Eur Radiol; 2022 Sep; 32(9):5943-5953. PubMed ID: 35332409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of DWI and ADC values in Ovarian-Adnexal Reporting and Data System (O-RADS) MRI score.
    Manganaro L; Ciulla S; Celli V; Ercolani G; Ninkova R; Miceli V; Cozzi A; Rizzo SM; Thomassin-Naggara I; Catalano C
    Radiol Med; 2023 May; 128(5):565-577. PubMed ID: 37097348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improving risk stratification of indeterminate adnexal masses on MRI: What imaging features help predict malignancy in O-RADS MRI 4 lesions?
    Wong BZY; Causa Andrieu PI; Sonoda Y; Chi DS; Aviki EM; Vargas HA; Woo S
    Eur J Radiol; 2023 Nov; 168():111122. PubMed ID: 37806193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnetic resonance scoring system for assessment of adnexal masses: added value of diffusion-weighted imaging including apparent diffusion coefficient map.
    Hottat NA; Van Pachterbeke C; Vanden Houte K; Denolin V; Jani JC; Cannie MM
    Ultrasound Obstet Gynecol; 2021 Mar; 57(3):478-487. PubMed ID: 32438461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative apparent diffusion coefficient metrics for MRI-only suspicious breast lesions: any added clinical value?
    Li X; Wang H; Gao J; Jiang L; Chen M
    Quant Imaging Med Surg; 2023 Oct; 13(10):7092-7104. PubMed ID: 37869329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. O-RADS MRI: A Systematic Review and Meta-Analysis of Diagnostic Performance and Category-wise Malignancy Rates.
    Rizzo S; Cozzi A; Dolciami M; Del Grande F; Scarano AL; Papadia A; Gui B; Gandolfo N; Catalano C; Manganaro L
    Radiology; 2023 Apr; 307(1):e220795. PubMed ID: 36413127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of adnexal lesions using photoacoustic imaging to improve sonographic O-RADS risk assessment.
    Zhu Q; Luo H; Middleton WD; Itani M; Hagemann IS; Hagemann AR; Hoegger MJ; Thaker PH; Kuroki LM; MCourt CK; Mutch DG; Powell MA; Siegel CL
    Ultrasound Obstet Gynecol; 2023 Dec; 62(6):891-903. PubMed ID: 37606287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accuracy and reproducibility of the O-RADS MRI risk stratification system based on enhanced non-DCE MRI in the assessment of adnexal masses.
    Wu M; Tang Q; Cai S; Zhu L; Lin C; Guan Y; Rao S; Zhou J
    Eur J Radiol; 2023 Feb; 159():110670. PubMed ID: 36584564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. O-RADS scoring system for adnexal lesions: Diagnostic performance on TVUS performed by an expert sonographer and MRI.
    Campos A; Villermain-Lécolier C; Sadowski EA; Bazot M; Touboul C; Razakamanantsoa L; Thomassin-Naggara I
    Eur J Radiol; 2023 Dec; 169():111172. PubMed ID: 37976101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combining b2500 diffusion-weighted imaging with BI-RADS improves the specificity of breast MRI.
    Saccenti L; Mellon CM; Scholer M; Jolibois Z; Stemmer A; Weiland E; de Bazelaire C
    Diagn Interv Imaging; 2023 Sep; 104(9):410-418. PubMed ID: 37208291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative Study of the Efficacy of the Ovarian-Adnexa Reporting and Data System Ultrasound Combined With Contrast-Enhanced Ultrasound and the ADNEX MR Scoring System in the Diagnosis of Adnexal Masses.
    Wang T; Cui W; Nie F; Huang X; Huang L; Liu L; Zhu Y; Zheng R
    Ultrasound Med Biol; 2023 Sep; 49(9):2072-2080. PubMed ID: 37321953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bridging Communication Gaps Between Radiologists, Referring Physicians, and Patients Through Standardized Structured Cancer Imaging Reporting: The Experience with Female Pelvic MRI Assessment Using O-RADS and a Simulated Cohort Patient Group.
    Woo S; Andrieu PC; Abu-Rustum NR; Broach V; Zivanovic O; Sonoda Y; Chi DS; Aviki E; Ellis A; Carayon P; Hricak H; Vargas HA
    Acad Radiol; 2024 Apr; 31(4):1388-1397. PubMed ID: 37661555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. O-RADS MRI scoring system has the potential to reduce the frequency of avoidable adnexal surgery.
    Dabi Y; Rockall A; Razakamanantsoa L; Guerra A; Fournier LS; Fotopoulou C; Touboul C; Thomassin-Naggara I;
    Eur J Obstet Gynecol Reprod Biol; 2024 Mar; 294():135-142. PubMed ID: 38237312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ovarian-Adnexal Reporting Data System Magnetic Resonance Imaging (O-RADS MRI) Score for Risk Stratification of Sonographically Indeterminate Adnexal Masses.
    Thomassin-Naggara I; Poncelet E; Jalaguier-Coudray A; Guerra A; Fournier LS; Stojanovic S; Millet I; Bharwani N; Juhan V; Cunha TM; Masselli G; Balleyguier C; Malhaire C; Perrot NF; Sadowski EA; Bazot M; Taourel P; Porcher R; Darai E; Reinhold C; Rockall AG
    JAMA Netw Open; 2020 Jan; 3(1):e1919896. PubMed ID: 31977064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Performance of IOTA Simple Rules, Simple Rules risk assessment, ADNEX model and O-RADS in differentiating between benign and malignant adnexal lesions in North American women.
    Hiett AK; Sonek JD; Guy M; Reid TJ
    Ultrasound Obstet Gynecol; 2022 May; 59(5):668-676. PubMed ID: 34533862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adding a Model-free Diffusion MRI Marker to BI-RADS Assessment Improves Specificity for Diagnosing Breast Lesions.
    Goto M; Le Bihan D; Yoshida M; Sakai K; Yamada K
    Radiology; 2019 Jul; 292(1):84-93. PubMed ID: 31112086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. O-RADS MRI Classification of Indeterminate Adnexal Lesions: Time-Intensity Curve Analysis Is Better Than Visual Assessment.
    Wengert GJ; Dabi Y; Kermarrec E; Jalaguier-Coudray A; Poncelet E; Porcher R; Thomassin-Naggara I; Rockall AG;
    Radiology; 2022 Jun; 303(3):566-575. PubMed ID: 35230183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined contrast-enhanced magnetic resonance and diffusion-weighted imaging reading adapted to the "Breast Imaging Reporting and Data System" for multiparametric 3-T imaging of breast lesions.
    Pinker K; Bickel H; Helbich TH; Gruber S; Dubsky P; Pluschnig U; Rudas M; Bago-Horvath Z; Weber M; Trattnig S; Bogner W
    Eur Radiol; 2013 Jul; 23(7):1791-802. PubMed ID: 23504036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.